Relationships of p16 Immunohistochemistry and Other Biomarkers With Diagnoses of Cervical Abnormalities: Implications for LAST Terminology.

Adult Biomarkers, Tumor / analysis Cyclin-Dependent Kinase Inhibitor p16 / analysis Female Humans Immunohistochemistry Middle Aged Papillomavirus Infections / complications Uterine Cervical Neoplasms / classification Uterine Cervical Dysplasia / classification

Journal

Archives of pathology & laboratory medicine
ISSN: 1543-2165
Titre abrégé: Arch Pathol Lab Med
Pays: United States
ID NLM: 7607091

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 14 11 2019
medline: 10 10 2020
entrez: 14 11 2019
Statut: ppublish

Résumé

Lower Anogenital Squamous Terminology (LAST) standardization recommended p16 To describe the relationships of p16 IHC and other biomarkers associated with cervical cancer risk with biopsy diagnoses. A statewide, stratified sample of cervical biopsies diagnosed by community pathologists (CPs), including 1512 CIN2, underwent a consensus, expert pathologist panel (EP) review (without p16 IHC results), p16 IHC interpretation by a third pathology group, and human papillomavirus (HPV) genotyping, results of which were grouped hierarchically according to cancer risk. Antecedent cytologic interpretations were also available. Biopsies were more likely to test p16 IHC positive with increasing severity of CP diagnoses, overall ( p16 IHC-positive, CP-diagnosed CIN2 appears to be lower cancer risk than CP-diagnosed CIN3. LAST classification of "HSIL" diagnosis, which includes p16 IHC-positive CIN2, should annotate the morphologic diagnosis (CIN2 or CIN3) to inform all management decisions, which is especially important for young (<30 years) women diagnosed with CIN2 for whom surveillance rather than treatment is recommended.

Identifiants

DOI: 10.5858/arpa.2019-0241-OA PMID: 31718233 PMC: PMC8575174
pubmed: 31718233
doi: 10.5858/arpa.2019-0241-OA
pmc: PMC8575174
mid: NIHMS1730807
doi:

Substances chimiques

Biomarkers, Tumor 0
CDKN2A protein, human 0
Cyclin-Dependent Kinase Inhibitor p16 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

725-734

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI113187
Pays : United States

Investigateurs

N E Joste (NE)
W K Kinney (WK)
C M Wheeler (CM)
W C Hunt (WC)
A Waxman (A)
S Jenison (S)
J C Gage (JC)
M Schiffman (M)
P E Castle (PE)
V Benard (V)
D Saslow (D)
J J Kim (JJ)
M H Stoler (MH)
J Cuzick (J)
P Gravitt (P)
G R Pressley (GR)
K English (K)
S M Bean (SM)
M J Beckmann (MJ)
C Benedict (C)
S Cherny (S)
V Ciocca (V)
B A Crothers (BA)
C Deng (C)
M Dvorakova (M)
F Fan (F)
M Ghofrani (M)
K Hanley (K)
D S Heller (DS)
M Husain (M)
K Jensen (K)
S Kerley (S)
L Korfhage (L)
K P Maniar (KP)
C Marshall (C)
K Matsukuma (K)
Z McCroskey (Z)
G Moore (G)
J Muir (J)
M Nowacki (M)
I T Ocal (IT)
D O’Connor (D)
L Scanga (L)
M Schinstine (M)
P Schlosshauer (P)
C Sturgis (C)
J Thomsen (J)
D Tokugawa (D)
E Unger (E)
K Volmar (K)
Y Wang (Y)
D West (D)
S White (S)
B Winkler (B)
A Yemelyanova (A)
C Zhao (C)

Références

Am J Surg Pathol. 2017 Feb;41(2):143-152
pubmed: 27680604
Int J Cancer. 2014 Feb 15;134(4):897-904
pubmed: 23913416
Obstet Gynecol. 2018 Sep;132(3):725-735
pubmed: 30095780
N Engl J Med. 2003 Feb 6;348(6):518-27
pubmed: 12571259
Am J Clin Pathol. 2007 May;127(5):805-15
pubmed: 17439841
Int J Clin Exp Pathol. 2015 Mar 01;8(3):2979-86
pubmed: 26045807
Am J Surg Pathol. 2018 Aug;42(8):1001-1009
pubmed: 29697437
Am J Clin Pathol. 1994 Aug;102(2):182-7
pubmed: 8042586
J Clin Microbiol. 2000 Jan;38(1):357-61
pubmed: 10618116
Am J Clin Pathol. 2011 Feb;135(2):212-20
pubmed: 21228361
Expert Rev Proteomics. 2012 Apr;9(2):149-63
pubmed: 22462787
Int J Gynaecol Obstet. 2016 Jul;134(1):45-8
pubmed: 27233813
J Natl Cancer Inst. 2009 Apr 1;101(7):475-87
pubmed: 19318628
Lancet Oncol. 2008 May;9(5):425-34
pubmed: 18407790
Mod Pathol. 2015 Jul;28(7):977-93
pubmed: 25953390
Am J Surg Pathol. 2015 Nov;39(11):1518-1528
pubmed: 26379150
Am J Surg Pathol. 2010 Aug;34(8):1077-87
pubmed: 20661011
Mod Pathol. 2017 Feb;30(2):304-310
pubmed: 27739439
Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1248-54
pubmed: 18483347
Cancer Res. 2009 Apr 15;69(8):3262-6
pubmed: 19351830
BMJ. 2018 Feb 27;360:k499
pubmed: 29487049
Int J Cancer. 2013 Jan 1;132(1):198-207
pubmed: 22532127
Mod Pathol. 2016 Jan;29(1):51-9
pubmed: 26541274
Arch Pathol Lab Med. 2014 Jan;138(1):76-87
pubmed: 24377814
Cancer Prev Res (Phila). 2018 Mar;11(3):165-170
pubmed: 29437696
Future Microbiol. 2011 Sep;6(9):1083-98
pubmed: 21958146
Lancet. 2007 Sep 8;370(9590):890-907
pubmed: 17826171
Am J Surg Pathol. 2015 Jun;39(6):729-36
pubmed: 25602796
Int J Cancer. 2013 Jan 15;132(2):327-34
pubmed: 22729477
Am J Surg Pathol. 2002 Nov;26(11):1389-99
pubmed: 12409715
Stat Med. 1985 Jan-Mar;4(1):87-90
pubmed: 3992076
Lancet Oncol. 2010 Nov;11(11):1048-56
pubmed: 20952254
Int J Cancer. 2012 Nov 15;131(10):2349-59
pubmed: 22323075
BJOG. 2016 Aug;123(9):1426-9
pubmed: 26695087
Int J Surg Pathol. 2012 Apr;20(2):146-53
pubmed: 22104735
Arch Pathol Lab Med. 2012 Oct;136(10):1266-97
pubmed: 22742517
Am J Clin Pathol. 2014 Jul;142(1):104-10
pubmed: 24926093
Mod Pathol. 2013 Feb;26(2):268-74
pubmed: 22996373
J Low Genit Tract Dis. 2013 Apr;17(5 Suppl 1):S1-S27
pubmed: 23519301
JAMA. 2001 Mar 21;285(11):1500-5
pubmed: 11255427
Am J Epidemiol. 2010 Jan 15;171(2):155-63
pubmed: 20007673
Am J Clin Pathol. 2008 Jul;130(1):65-70
pubmed: 18550472
J Clin Pathol. 2018 Nov;71(11):981-988
pubmed: 30012698
Int J Surg Pathol. 2014 May;22(3):221-30
pubmed: 23883975
J Low Genit Tract Dis. 2016 Jul;20(3):197-200
pubmed: 26855142
Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1595-1599
pubmed: 27587789
BMJ. 2016 Jul 28;354:i3633
pubmed: 27469988
Obstet Gynecol Surv. 1969 Jul;24(7 Pt 2):874-9
pubmed: 5212434
Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):230-40
pubmed: 25363635
Int J Gynecol Pathol. 2007 Oct;26(4):441-6
pubmed: 17885496
Am J Clin Pathol. 2014 Dec;142(6):767-72
pubmed: 25389329
JAMA. 2002 Apr 24;287(16):2114-9
pubmed: 11966386
J Infect Dis. 2001 Jun 1;183(11):1554-64
pubmed: 11343204
J Pathol. 1999 Sep;189(1):12-9
pubmed: 10451482

Auteurs

Philip E Castle (PE)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Rachael Adcock (R)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Jack Cuzick (J)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Nicolas Wentzensen (N)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Norah E Torrez-Martinez (NE)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Salina M Torres (SM)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Mark H Stoler (MH)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Brigitte M Ronnett (BM)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Nancy E Joste (NE)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Teresa M Darragh (TM)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Patti E Gravitt (PE)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Mark Schiffman (M)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

William C Hunt (WC)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Walter K Kinney (WK)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Cosette M Wheeler (CM)

From Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (Dr Castle); Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom (Ms Adcock and Dr Cuzick); Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland (Drs Wentzensen and Schiffman); the Department of Pathology, University of New Mexico Cancer Center, Albuquerque (Ms Torrez-Martinez, Dr Torres, Dr Joste, Dr Gravitt, Mr Hunt, and Dr Wheeler); the Department of Pathology, University of Virginia Health System, Charlottesville (Dr Stoler); the Department of Pathology, Johns Hopkins University, Baltimore, Maryland (Dr Ronnett); the Department of Pathology, University of California, San Francisco (Dr Darragh); and Sacramento, California (Dr Kinney).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Relationships of p16 Immunohistochemistry and...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Marqueurs biologiques tumoraux › Relationships of p16 Immunohistochemistry and...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines tumorales › Protéines suppresseurs de tumeurs › Protéines inhibitrices des kinases cyclines-dépendantes › Inhibiteur p16 de kinase cycline-dépendante › Relationships of p16 Immunohistochemistry and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Relationships of p16 Immunohistochemistry and...
questionsmedicales.fr › Disciplines des sciences naturelles › Chimie › Biochimie › Immunohistochimie › Relationships of p16 Immunohistochemistry and...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Relationships of p16 Immunohistochemistry and...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladies transmissibles › Maladies sexuellement transmissibles › Maladies sexuellement transmissibles virales › Infections à papillomavirus › Relationships of p16 Immunohistochemistry and...
questionsmedicales.fr › Maladies urogénitales › Tumeurs de l'appareil urogénital › Tumeurs de l'appareil génital féminin › Tumeurs de l'utérus › Tumeurs du col de l'utérus › Relationships of p16 Immunohistochemistry and...
questionsmedicales.fr › Maladies urogénitales › Maladies génitales › Maladies de l'appareil génital féminin › Maladies de l'utérus › Maladies du col utérin › Dysplasie du col utérin › Relationships of p16 Immunohistochemistry and...